132 related articles for article (PubMed ID: 11998605)
1. New therapeutic options in colon cancer: focus on oxaliplatin.
Wilkes GM
Clin J Oncol Nurs; 2002; 6(3):131-7. PubMed ID: 11998605
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of colon cancer: current status and future directions.
Chung KY; Saltz LB
Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
[TBL] [Abstract][Full Text] [Related]
3. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
Grothey A; Sargent DJ
J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
[No Abstract] [Full Text] [Related]
4. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.
Baker DE
Rev Gastroenterol Disord; 2003; 3(1):31-8. PubMed ID: 12684591
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.
Oncology (Williston Park); 2004 Sep; 18(10):1313. PubMed ID: 15526833
[No Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.
Prescrire Int; 2006 Jun; 15(83):109-1. PubMed ID: 16764102
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Land SR; Kopec JA; Cecchini RS; Ganz PA; Wieand HS; Colangelo LH; Murphy K; Kuebler JP; Seay TE; Needles BM; Bearden JD; Colman LK; Lanier KS; Pajon ER; Cella D; Smith RE; O'Connell MJ; Costantino JP; Wolmark N
J Clin Oncol; 2007 Jun; 25(16):2205-11. PubMed ID: 17470850
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin (Eloxatin) for advanced colon cancer.
Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
[No Abstract] [Full Text] [Related]
11. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
12. Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients.
Burz C; Berindan-Neagoe IB; Balacescu O; Tanaselia C; Ursu M; Gog A; Vlase L; Chintoanu M; Balacescu L; Leucuta SE; Irimie A; Cristea V
J Gastrointestin Liver Dis; 2009 Mar; 18(1):39-43. PubMed ID: 19337632
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
Berg D
Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
17. [Colon cancer: what is new in 2004?].
André T; Louvet C; de Gramont A
Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options in the management of colon cancer: 2005 update.
Wilkes GM
Clin J Oncol Nurs; 2005 Feb; 9(1):31-44. PubMed ID: 15751497
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin: a review of approved uses.
Stein A; Arnold D
Expert Opin Pharmacother; 2012 Jan; 13(1):125-37. PubMed ID: 22149372
[TBL] [Abstract][Full Text] [Related]
20. Innovative chemotherapies for stage III colon cancer: a cost-effectiveness study.
Koperna T; Semmler D
Hepatogastroenterology; 2003; 50(54):1903-9. PubMed ID: 14696430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
